EverImmune
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of Oncobax®-AK in Patients With Advanced Solid Tumors (NCT05865730) | EverImmune | 2022-10-01 |
Track EverImmune automatically
Every clearance here is in the API, with alerts when new ones post.